» Articles » PMID: 28437540

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

Abstract

Importance: Amyotrophic lateral sclerosis (ALS) is a common adult-onset neurodegenerative disease characterized by selective loss of upper and lower motor neurons. Patients with ALS have persistent peripheral and central inflammatory responses including abnormally functioning T cells and activated microglia. However, much less is known about the inflammatory gene profile of circulating innate immune monocytes in these patients.

Objective: To characterize the transcriptomics of peripheral monocytes in patients with ALS.

Design, Setting, And Participants: Monocytes were isolated from peripheral blood of 43 patients with ALS and 22 healthy control individuals. Total RNA was extracted from the monocytes and subjected to deep RNA sequencing, and these results were validated by quantitative reverse transcription polymerase chain reaction.

Main Outcomes And Measures: The differential expressed gene signatures of these monocytes were identified using unbiased RNA sequencing strategy for gene expression profiling.

Results: The demographics between the patients with ALS (mean [SD] age, 58.8 [1.57] years; 55.8% were men and 44.2% were women; 90.7% were white, 4.65% were Hispanic, 2.33% were black, and 2.33% were Asian) and control individuals were similar (mean [SD] age, 57.6 [2.15] years; 50.0% were men and 50.0% were women; 90.9% were white, none were Hispanic, none were black, and 9.09% were Asian). RNA sequencing data from negative selected monocytes revealed 233 differential expressed genes in ALS monocytes compared with healthy control monocytes. Notably, ALS monocytes demonstrated a unique inflammation-related gene expression profile, the most prominent of which, including IL1B, IL8, FOSB, CXCL1, and CXCL2, were confirmed by quantitative reverse transcription polymerase chain reaction (IL8, mean [SE], 1.00 [0.18]; P = .002; FOSB, 1.00 [0.21]; P = .009; CXCL1, 1.00 [0.14]; P = .002; and CXCL2, 1.00 [0.11]; P = .01). Amyotrophic lateral sclerosis monocytes from rapidly progressing patients had more proinflammatory DEGs than monocytes from slowly progressing patients.

Conclusions And Relevance: Our data indicate that ALS monocytes are skewed toward a proinflammatory state in the peripheral circulation and may play a role in ALS disease progression, especially in rapidly progressing patients. This increased inflammatory response of peripheral immune cells may provide a potential target for disease-modifying therapy in patients with ALS.

Citing Articles

Elevated Serum MCP-2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients.

Chowdhury R, Azam M, Azam S, Lana S, Culver E, Garruto R Eur J Neurol. 2025; 32(3):e70088.

PMID: 39996599 PMC: 11851731. DOI: 10.1111/ene.70088.


A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.

Rubio A, Hamilton L, Bausch M, Jin M, Papetti A, Jiang P J Neuroimmune Pharmacol. 2025; 20(1):23.

PMID: 39987404 PMC: 11846768. DOI: 10.1007/s11481-025-10181-x.


Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course.

Zucchi E, Banchelli F, Simonini C, De Biasi S, Martinelli I, Gianferrari G Front Immunol. 2025; 15():1508974.

PMID: 39845951 PMC: 11750661. DOI: 10.3389/fimmu.2024.1508974.


Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis.

Faller K, Chaytow H, Gillingwater T Nat Rev Neurol. 2025; 21(2):86-102.

PMID: 39743546 DOI: 10.1038/s41582-024-01049-4.


Immune mechanisms and shared immune targets in neurodegenerative diseases.

Weiner H Nat Rev Neurol. 2024; 21(2):67-85.

PMID: 39681722 DOI: 10.1038/s41582-024-01046-7.


References
1.
Butovsky O, Jedrychowski M, Cialic R, Krasemann S, Murugaiyan G, Fanek Z . Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2014; 77(1):75-99. PMC: 4432483. DOI: 10.1002/ana.24304. View

2.
Babu G, Kumar A, Chandra R, Puri S, Kalita J, Misra U . Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem Res. 2008; 33(6):1145-9. DOI: 10.1007/s11064-007-9564-x. View

3.
Lin Y, Golovnina K, Chen Z, Lee H, Serrano Negron Y, Sultana H . Comparison of normalization and differential expression analyses using RNA-Seq data from 726 individual Drosophila melanogaster. BMC Genomics. 2016; 17:28. PMC: 4702322. DOI: 10.1186/s12864-015-2353-z. View

4.
Butovsky O, Siddiqui S, Gabriely G, Lanser A, Dake B, Murugaiyan G . Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012; 122(9):3063-87. PMC: 3428086. DOI: 10.1172/JCI62636. View

5.
Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View